1. |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69(1): 7-34.
|
2. |
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol, 2015, 10(9): 1243-1260.
|
3. |
Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol, 2021, 220(2): e202009045.
|
4. |
Hou G, Yang J, Tang J, et al. LncRNA GAS6-AS2 promotes non-small-cell lung cancer cell proliferation via regulating miR-144-3p/ MAPK6 axis. Cell Cycle, 2021, 20(2): 179-193.
|
5. |
Huang Z, Zhuo W, Xu R, et al. The relationship between long noncoding RNA (lncRNA) small nucleolar RNA host gene 12 (SNHG12) expression in solid malignant tumors and prognosis of tumor patients: A systematic review and meta-analysis. Medicine (Baltimore), 2020, 99(41): e22247.
|
6. |
Rajagopal T, Talluri S, Akshaya RL, et al. HOTAIR LncRNA: A novel oncogenic propellant in human cancer. Clin Chim Acta, 2020, 503: 1-18.
|
7. |
Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell, 2018, 172(3): 393-407.
|
8. |
Du Z, Sun T, Hacisuleyman E, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun, 2016, 7: 10982.
|
9. |
Batista PJ, Chang HY. Long noncoding RNAs: Cellular address codes in development and disease. Cell, 2013, 152(6): 1298-1307.
|
10. |
Seo D, Kim D, Chae Y, et al. The ceRNA network of lncRNA and miRNA in lung cancer. Genomics Inform, 2020, 18(4): e36.
|
11. |
Shen Y, Peng X, Shen C. Identification and validation of immune-related lncRNA prognostic signature for breast cancer. Genomics, 2020, 112(3): 2640-2646.
|
12. |
Xu C, Liu M, Jia D, et al. lncRNA TINCR SNPs and expression levels are associated with bladder cancer susceptibility. Genet Test Mol Biomarkers, 2021, 25(1): 31-41.
|
13. |
Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell, 2011, 146(3): 353-358.
|
14. |
Su K, Wang N, Shao Q, et al. The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression. Biomed Pharmacother, 2021, 137: 111389.
|
15. |
Liang Y, Rong X, Luo Y, et al. A novel long non-coding RNA LINC00355 promotes proliferation of lung adenocarcinoma cells by down-regulating miR-195 and up-regulating the expression of CCNE1. Cell Signal, 2020, 66: 109462.
|
16. |
Ma T, Hu Y, Guo Y, et al. Tumor-promoting activity of long noncoding RNA LINC00466 in lung adenocarcinoma via miR-144-regulated HOXA10 axis. Am J Pathol, 2019, 189(11): 2154-2170.
|
17. |
Han M, Gu Y, Lu P, et al. Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation. Mol Cancer, 2020, 19(1): 26.
|
18. |
Zhou Y, Shi X, Chen H, et al. Tumor immune microenvironment characterization of primary lung adenocarcinoma and lymph node metastases. Biomed Res Int, 2021, 2021: 5557649.
|
19. |
Dang Y, Ouyang X, Ren W, et al. LncRNA AFAP1-AS1 modulates the proliferation and invasion of gastric cancer cells by regulating AFAP1 via miR-205-5p. Cancer Manag Res, 2021, 13: 5163-5175.
|
20. |
Tang J, Zhong G, Wu J, et al. Long noncoding RNA AFAP1-AS1 facilitates tumor growth through enhancer of zeste homolog 2 in colorectal cancer. Am J Cancer Res, 2018, 8(5): 892-902.
|
21. |
Wu W, Bhagat TD, Yang X, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology, 2013, 144(5): 956-966.
|
22. |
Sun J, Min H, Yu L, et al. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer. Anticancer Drugs, 2021, 32(1): 11-21.
|